- Year selection
- 2022
- 2033
-
2024-03-26
VOLUNTARY ANNOUNCEMENT - THE FIRST PATIENT ENROLLED IN PHASE II CLINICAL TRIAL OF M701, A BISPECIFIC ANTIBODY FOR TREATMENT OF MALIGNANT PLEURAL EFFUSION
-
2024-03-15
Date of Board Meeting
-
2024-03-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
-
2024-02-28
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
-
2024-02-28
Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
-
2024-02-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
-
2024-01-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
-
2023-12-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
-
2023-11-16
Articles of Association
-
2023-11-16
POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2023
E-Mail：info@yzybio.com
Address：Biolake, C2-1, No. 666 High-tech Avenue, Wuhan, Hubei, China
